|
[1]
|
Al-Hendy, A., Myers, E. and Stewart, E. (2017) Uterine Fibroids: Burden and Unmet Medical Need. Seminars in Reproductive Medicine, 35, 473-480. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Day Baird, D., Dunson, D.B., Hill, M.C., et al. (2003) High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence. American Journal of Obstetrics and Gynecology, 188, 100-107. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wise, L.A. and Laughlin-Tommaso, S.K. (2016) Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clinical Obstetrics and Gynecology, 59, 2-24.
|
|
[4]
|
Li, S. and Mclachlan, J.A. (2001) Estrogen-Associated Genes in Uterine Leiomyoma. Annals of the New York Academy of Sciences, 948, 112-120. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pedeutour, F., Quade, B.J., Weremowicz, S., et al. (1998) Localization and Expression of the Human Estrogen Receptor β Gene in Uterine Leiomyomata. Genes, Chromosomes and Cancer, 23, 361-366. [Google Scholar] [CrossRef]
|
|
[6]
|
Cardozo, E.R., Clark, A.D., Banks, N.K., et al. (2012) The Estimated Annual Cost of Uterine Leiomyomata in the United States. American Journal of Obstetrics and Gynecology, 206, 211.E1-211.E9. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Baird D.D., Patchel, S.A., Saldana, T.M, et al. (2020) Uterine Fibroid Incidence and Growth in an Ultrasound-Based, Prospective Study of Young African Americans. American Journal of Obstetrics and Gynecology, 223, 402.E1-402.E18. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Flake, G.P., Andersen, J. and Dixon, D. (2003) Etiology and Pathogenesis of Uterine Leiomyomas: A Review. Environmental Health Perspectives, 111, 1037-1054. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wise, L.A. (2004) Reproductive Factors, Hormonal Contraception, and Risk of Uterine Leiomyomata in African-American Women: A Prospective Study. American Journal of Epidemiology, 159, 113-123. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Marshall, L. (1997) Variation in the Incidence of Uterine Leiomyoma among Premenopausal Women by Age and Race. Obstetrics & Gynecology, 90, 967-973. [Google Scholar] [CrossRef]
|
|
[11]
|
Al-Hendy, A. and Salama, S.A. (2006) Catechol-O-Methyltransferase Polymorphism Is Associated with Increased Uterine Leiomyoma Risk in Different Ethnic Groups. Journal of the Society for Gynecologic Investigation, 13, 136-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Qin, H., Lin, Z., Vásquez, E., et al. (2020) Association between Obesity and the Risk of Uterine Fibroids: A Systematic Review and Meta-Analysis. Journal of Epidemiology and Community Health, 75, 197-204. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ross, R.K., Pike, M.C., Vessey, M.P., et al. (1986) Risk Factors for Uterine Fibroids: Reduced Risk Associated with Oral Contraceptives. BMJ: British Medical Journal, 293, 359-362. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Shozu, M. and Inoue, M. (2004) Aromatase and Leiomyoma of the Uterus. Seminars in Reproductive Medicine, 22, 51-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Soave, I. and Marci, R. (2018) From Obesity to Uterine Fibroids: An Intricate Network. Current Medical Research and Opinion, 34, 1877-1879. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Maggio, M., Lauretani, F., Basaria, S., et al. (2008) Sex Hormone Binding Globulin Levels Across the Adult Lifespan in Women—The Role of Body Mass Index and Fasting Insulin. Journal of Endocrinological Investigation, 31, 597-601. [Google Scholar] [CrossRef]
|
|
[17]
|
Salehi, A.M., Jenabi, E., Farashi, S., et al. (2023) The Environmental Risk Factors Related to Uterine Leiomyoma: An Umbrella Review. Journal of Gynecology Obstetrics and Human Reproduction, 52, Article ID: 102517. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Dhama, K., Latheef, S.K., Dadar, M., et al. (2019) Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Frontiers in Molecular Biosciences, 6, Article 465402. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Herrera, A.Y., Nielsen, S.E. and Mather, M. (2016) Stress-Induced Increases in Progesterone and Cortisol in Naturally Cycling Women. Neurobiology of Stress, 3, 96-104. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wise, L.A., Palmer, J.R., Stewart, E.A., et al. (2005) Age-Specific Incidence Rates for Self-Reported Uterine Leiomyomata in the Black Womenʼs Health Study. Obstetrics & Gynecology, 105, 563-568. [Google Scholar] [CrossRef]
|
|
[21]
|
Shen, Y., Xu, Q., Xu, J., et al. (2013) Environmental Exposure and Risk of Uterine Leiomyoma: An Epidemiologic Survey. European Review for Medical and Pharmacological Sciences, 17, 3249-3256.
|
|
[22]
|
Fung, T.T., Schulze, M.B., Hu, F.B., et al. (2012) A Dietary Pattern Derived to Correlate with Estrogens and Risk of Postmenopausal Breast Cancer. Breast Cancer Research and Treatment, 132, 1157-1162. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Masala, G., Assedi, M., Bendinelli, B., et al. (2012) Fruit and Vegetables Consumption and Breast Cancer Risk: The EPIC Italy Study. Breast Cancer Research and Treatment, 132, 1127-1136. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chiaffarino, F., Parazzini, F., La Vecchia, C., Chatenoud, L., Di Cintio, E. and Marsico, S. (1999) Diet and Uterine Myomas. Obstetrics & Gynecology, 94, 395-398.
|
|
[25]
|
Michnovicz, J.J. and Bradlow, H.L. (1990) Dietary and Pharmacological Control of Estradiol Metabolism in Humans. Annals of the New York Academy of Sciences, 595, 291-299.
|
|
[26]
|
Wise, L.A., Radin, R.G., Palmer, J.R., et al. (2011) Intake of Fruit, Vegetables, and Carotenoids in Relation to Risk of Uterine Leiomyomata. The American Journal of Clinical Nutrition, 94, 1620-1631. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Gao, M. and Wang, H. (2018) Frequent Milk and Soybean Consumption Are High Risks for Uterine Leiomyoma—A Prospective Cohort Study. Medicine, 97, e12009. [Google Scholar] [CrossRef]
|
|
[28]
|
Orta, O.R., Terry, K.L., Missmer, S.A., et al. (2020) Dairy and Related Nutrient Intake and Risk of Uterine Leiomyoma: A Prospective Cohort Study. Human Reproduction, 35, 453-463. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Peiris, A.N., Bailey, B.A., Peiris, P., et al. (2011) Race and Vitamin D Status and Monitoring in Male Veterans. Journal of the National Medical Association, 103, 492-497. [Google Scholar] [CrossRef]
|
|
[30]
|
Rostand, S.G. (2010) Vitamin D, Blood Pressure, and African Americans: Toward a Unifying Hypothesis. Clinical Journal of the American Society of Nephrology, 5, 1697-1703. [Google Scholar] [CrossRef]
|
|
[31]
|
Brakta, S., Diamond, J.S., Al-Hendy, A., et al. (2015) Role of Vitamin D in Uterine Fibroid Biology. Fertility and Sterility, 104, 698-706. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Baker, A.R., Mcdonnell, D.P., Hughes, M., et al. (1988) Cloning and Expression of Full-Length CDNA Encoding Human Vitamin D Receptor. Proceedings of the National Academy of Sciences of the United States of America, 85, 3294-3298. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Mcdonnell, D.P., Mangelsdorf, D.J., Pike, J.W., et al. (1987) Molecular Cloning of Complementary DNA Encoding the Avian Receptor for Vitamin D. Science, 235, 1214-1217. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Bläuer, M., Rovio, P.H., Ylikomi, T., et al. (2009) Vitamin D Inhibits Myometrial and Leiomyoma Cell Proliferation in Vitro. Fertility and Sterility, 91, 1919-1925. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Prentice, A. (2008) Vitamin D Deficiency: A Global Perspective. Nutrition Reviews, 66, S153-S164. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Prentice, A., Schoenmakers, I., Jones, K.S., et al. (2009) Vitamin D Deficiency and Its Health Consequences in Africa. Clinical Reviews in Bone and Mineral Metabolism, 7, 94-106. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zhao, G., Ford, E.S., Tsai, J., et al. (2012) Factors Associated with Vitamin D Deficiency and Inadequacy among Women of Childbearing Age in the United States. International Scholarly Research Notices, 2012, Article ID: 691486. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Paffoni, A., Somigliana, E., Vigano’, P., et al. (2013) Vitamin D Status in Women with Uterine Leiomyomas. The Journal of Clinical Endocrinology & Metabolism, 98, E1374-E1378. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Templeman, C., Marshall, S.F., Clarke, C.A., et al. (2009) Risk Factors for Surgically Removed Fibroids in a Large Cohort of Teachers. Fertility and Sterility, 92, 1436-1446. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Marshall, L.M., Spiegelman, D., Goldman, M.B., et al. (1998) A Prospective Study of Reproductive Factors and Oral Contraceptive Use in Relation to the Risk of Uterine Leiomyomata. Fertility and Sterility, 70, 432-439. [Google Scholar] [CrossRef]
|
|
[41]
|
Faerstein, E., Szklo, M. and Rosenshein, N. (2001) Risk Factors for Uterine Leiomyoma: A Practice-Based Case-Control Study. I. African-American Heritage, Reproductive History, Body Size, and Smoking. American Journal of Epidemiology, 153, 1-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Terry, K.L., De Vivo, I., Hankinson, S.E., et al. (2010) Reproductive Characteristics and Risk of Uterine Leiomyomata. Fertility and Sterility, 94, 2703-2707. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Bernstein, L., Pike, M.C., Ross, R.K., et al. (1991) Age at Menarche and Estrogen Concentrations of Adult Women. Cancer Causes & Control, 2, 221-225. [Google Scholar] [CrossRef]
|
|
[44]
|
Apter, D., Bolton, N.J., Hammond, G.L. and Vihko, R. (1984) Serum Sex Hormone-Binding Globulin during Puberty in Girls and in Different Types of Adolescent Menstrual Cycles. Acta Endocrinologica, 107, 413-419. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Apter, D. and Vihko, R. (1983) Early Menarche, a Risk Factor for Breast Cancer, Indicates Early Onset of Ovulatory Cycles. The Journal of Clinical Endocrinology & Metabolism, 57, 82-86. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Chen, C.R., Buck, G.M., Courey, N.G., et al. (2001) Risk Factors for Uterine Fibroids among Women Undergoing Tubal Sterilization. American Journal of Epidemiology, 153, 20-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Marino, J.L., Eskenazi, B., Warner, M., et al. (2004) Uterine Leiomyoma and Menstrual Cycle Characteristics in a Population-Based Cohort Study. Human Reproduction, 19, 2350-2355. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Baird, D.D. and Dunson, D.B. (2003) Why Is Parity Protective for Uterine Fibroids? Epidemiology, 14, 247-250. [Google Scholar] [CrossRef]
|
|
[49]
|
Qin, J., Yang, T., Kong, F., et al. (2013) Oral Contraceptive Use and Uterine Leiomyoma Risk: A Meta-Analysis Based on Cohort and Case-Control Studies. Archives of Gynecology and Obstetrics, 288, 139-148. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Ikomi, A.A. and Singer, A. (1997) Protective Effect of Depot-Medroxyprogesterone Acetate on Surgically Treated Uterine Leiomyomas: A Multicentre Case-Control Study. BJOG: An International Journal of Obstetrics and Gynaecology, 104, 385-386. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Faerstein, E., Szklo, M., Rosenshein, N.B. (2001) Risk Factors for Uterine Leiomyoma: A Practice-Based Case-Control Study. II. Atherogenic Risk Factors and Potential Sources of Uterine Irritation. American Journal of Epidemiology, 153, 11-19. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Silver, M.A., Raghuvir, R., Fedirko, B., et al. (2005) Systemic Hypertension among Women with Uterine Leiomyomata: Potential Final Common Pathways of Target End-Organ Remodeling. The Journal of Clinical Hypertension, 7, 664-668. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Takeda, T., Sakata, M., Isobe, A., et al. (2008) Relationship between Metabolic Syndrome and Uterine Leiomyomas: A Case-Control Study. Gynecologic and Obstetric Investigation, 66, 14-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Boynton-Jarrett, R. (2005) A Prospective Study of Hypertension and Risk of Uterine Leiomyomata. American Journal of Epidemiology, 161, 628-638. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Radin, R.G., Rosenberg, L., Palmer, J.R., et al. (2012) Hypertension and Risk of Uterine Leiomyomata in US Black Women. Human Reproduction, 27, 1504-1509. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Chen, Y., Lin, M., Guo, P., et al. (2021) Uterine Fibroids Increase the Risk of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study. Journal of Hypertension, 39, 1002-1008. [Google Scholar] [CrossRef]
|
|
[57]
|
Radin, R.G., Palmer, J.R., Rosenberg, L., et al. (2010) Dietary Glycemic Index and Load in Relation to Risk of Uterine Leiomyomata in the Black Women’s Health Study. The American Journal of Clinical Nutrition, 91, 1281-1288. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
D’Aloisio, A.A., Baird, D.D., Deroo, L.A., et al. (2010) Association of Intrauterine and Early-Life Exposures with Diagnosis of Uterine Leiomyomata by 35 Years of Age in the Sister Study. Environmental Health Perspectives, 118, 375-381. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Yang, C.H., Lee, J.N., Hsu, S.C., et al. (2002) Effect of Hormone Replacement Therapy on Uterine Fibroids in Postmenopausal Women—A 3-Year Study. Maturitas, 43, 35-39. [Google Scholar] [CrossRef]
|
|
[60]
|
Chang, I.J., Hong, G.Y., Oh, Y.L., et al. (2013) Effects of Menopausal Hormone Therapy on Uterine Myoma in Menopausal Women. Journal of Menopausal Medicine, 19, 123-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Palomba, S., Sena, T., Noia, R., et al. (2001) Transdermal Hormone Replacement Therapy in Postmenopausal Women with Uterine Leiomyomas. Obstetrics & Gynecology, 98, 1053-1058. [Google Scholar] [CrossRef]
|
|
[62]
|
Palomba, S., Orio, F., Russo, T., et al. (2005) Antiproliferative and Proapoptotic Effects of Raloxifene on Uterine Leiomyomas in Postmenopausal Women. Fertility and Sterility, 84, 154-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Jirecek, S., Lee, A., Pavo, I., et al. (2004) Raloxifene Prevents the Growth of Uterine Leiomyomas in Premenopausal Women. Fertility and Sterility, 81, 132-136. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Palomba, S., Sammartino, A., Di Carlo, C., et al. (2001) Effects of Raloxifene Treatment on Uterine Leiomyomas in Postmenopausal Women. Fertility and Sterility, 76, 38-43. [Google Scholar] [CrossRef]
|
|
[65]
|
Bilge, Şener, A., Seçkin, N.C., Özmen, Ş., et al. (1996) The Effects of Hormone Replacement Therapy on Uterine Fibroids in Postmenopausal Women. Fertility and Sterility, 65, 354-357. [Google Scholar] [CrossRef]
|
|
[66]
|
Polatti, F., Viazzo, F., Colleoni, R., et al. (2000) Uterine Myoma in Postmenopause: A Comparison between Two Therapeutic Schedules of HRT. Maturitas, 37, 27-32. [Google Scholar] [CrossRef]
|
|
[67]
|
Palomba, S., Sena, T., Morelli, M., et al. (2002) Effect of Different Doses of Progestin on Uterine Leiomyomas in Postmenopausal Women. European Journal of Obstetrics & Gynecology and Reproductive Biology, 102, 199-201. [Google Scholar] [CrossRef]
|